ArticleInternational journal of hematology2024

Changes in chronic myeloid leukemia treatment modalities and outcomes after introduction of second-generation tyrosine kinase inhibitors as first-line therapy: a multi-institutional retrospective study by the CML Cooperative Study Group.

Noriyoshi Iriyama et al.PubMed ↗Publisher ↗

No numbers read from the abstract.